Successful valve-in-valve transcatheter intervention to treat severe stenosis of a 38-year-old tricuspid bioprosthesis

A 60-year-old man presented with breathlessness. Nearly four decades previously, he had required three operations for Staphylococcus aureus infective endocarditis of the tricuspid valve and had received a bioprosthetic valve. He had critical tricuspid bioprosthesis stenosis which was treated successfully by valve-in-valve transcatheter tricuspid valve replacement using a balloon-expandable transcatheter heart valve. One year after intervention, the patient is well with no tricuspid valve stenosis or regurgitation. A 60-year-old man, who had undergone tricuspid valve surgery three times in the early 1980s for infective endocarditis, presented with critical stenosis of the tricuspid bioprosthesis 38 years after implantation. He was successfully treated by a valve-in-valve transcatheter tricuspid valve implantation procedure. This case illustrates how transcatheter therapies have helped transform the treatment of patients that have had previous valve replacement, especially those that have had multiple cardiac surgeries. image